Pennsylvania 2025-2026 Regular Session

Pennsylvania House Bill HB1411

Introduced
5/6/25  

Caption

In powers and duties of the Department of Health and its departmental administrative and advisory boards, providing for perimenopause and menopause education.

Impact

By formally recognizing and training healthcare professionals on the complexities of perimenopause and menopause, HB1411 is positioned to improve the health outcomes for women experiencing these transitions. Local health providers will have the resources necessary to educate patients effectively, hence promoting a better understanding of women's health issues. The involvement of the Department of Health emphasizes a state-level commitment to addressing this often-overlooked area of healthcare.

Summary

House Bill 1411 aims to enhance women's health education specifically focusing on perimenopause and menopause. The bill amends the Administrative Code of 1929 to empower the Department of Health to engage with healthcare providers and community health centers, facilitating educational initiatives that inform women about the symptoms and processes related to perimenopause and menopause. This includes the development of both electronic and physical informational materials that would be accessible to women undergoing these life changes.

Sentiment

The sentiment around HB1411 appears to be generally supportive, particularly from advocacy groups and health professionals who recognize the need for comprehensive educational resources tailored to women's health. The support reflects a consensus on the importance of empowering women with knowledge about their health during significant biological changes. However, there may be some contention regarding the funding and implementation of such programs, as well as how effectively these educational materials will be disseminated among the diverse populations in Pennsylvania.

Contention

While the bill presents an opportunity for enhanced public health education, potential points of contention could arise regarding the allocation of resources necessary for the education programs. Questions may be raised about the effectiveness of the partnerships formed by the Department of Health and whether the educational materials provided will meet the varied needs of all demographics. Furthermore, the bill's implementation timeline and measuring its success may also be potential areas for discussion and debate in legislative circles.

Companion Bills

No companion bills found.

Similar Bills

OH HB767

Enact Menopause, Perimenopause, and Hormone Therapy Coverage Act

MA H5303

Expanding access to perimenopause and menopause care

NJ S4054

Clarifies that testosterone therapy is covered treatment under the "New Jersey Menopause Coverage Act."

NJ A4642

Clarifies that testosterone therapy is covered treatment under the "New Jersey Menopause Coverage Act."

CA AB432

Menopause.

PA SB1118

In powers and duties of the Department of Health and its departmental administrative and advisory boards, providing for perimenopause and menopause education.

MI SB0718

Insurance: health insurers; coverage for treatment of menopause and perimenopause symptoms and waiver of prior authorization for prescription drugs or treatments for menopause and perimenopause symptoms; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406zz.

MI HB4814

Insurance: health insurers; coverage for treatment of menopause and perimenopause symptoms and waiver of prior authorization for prescription drugs or treatments for menopause and perimenopause symptoms; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406zz.